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Background: Quantitative assessment of myocardial blood flow (MBF) from cardiovascular magnetic resonance
(CMR) perfusion images appears to offer advantages over qualitative assessment. Currently however, clinical
translation is lacking, at least in part due to considerable disparity in quantification methodology. The aim of this
study was to evaluate the effect of common methodological differences in CMR voxel-wise measurement of MBF,
using position emission tomography (PET) as external validation.
Methods: Eighteen subjects, including 9 with significant coronary artery disease (CAD) and 9 healthy volunteers
prospectively underwent perfusion CMR. Comparison was made between MBF quantified using: 1. Calculated
contrast agent concentration curves (to correct for signal saturation) versus raw signal intensity curves; 2. Mid-
ventricular versus basal-ventricular short-axis arterial input function (AIF) extraction; 3. Three different deconvolution
approaches; Fermi function parameterization, truncated singular value decomposition (TSVD) and first-order Tikhonov
regularization with b-splines. CAD patients also prospectively underwent rubidium-82 PET (median interval 7 days).
Results: MBF was significantly higher when calculated using signal intensity compared to contrast agent concentration
curves, and when the AIF was extracted from mid- compared to basal-ventricular images. MBF did not differ
significantly between Fermi and Tikhonov, or between Fermi and TVSD deconvolution methods although there was a
small difference between TSVD and Tikhonov (0.06 mL/min/g). Agreement between all deconvolution methods was
high. MBF derived using each CMR deconvolution method showed a significant linear relationship (p < 0.001) with
PET-derived MBF however each method underestimated MBF compared to PET (by 0.19 to 0.35 mL/min/g).
Conclusions: Variations in more complex methodological factors such as deconvolution method have no greater
effect on estimated MBF than simple factors such as AIF location and observer variability. Standardization of the
quantification process will aid comparison between studies and may help CMR MBF quantification enter clinical use.
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Myocardial ischaemia is a fundamental determinant of
prognosis and non-invasive imaging assessment of ischae-
mia is integral to the management of patients with sus-
pected or established coronary artery disease (CAD) [1].
Cardiovascular magnetic resonance (CMR) perfusion im-
aging, involving qualitative assessment of the first-pass of
contrast agent though the myocardium, has emerged as
an effective method of diagnosing CAD [2]. Visual inter-
pretation however is limited to providing information on
the regional distribution of MBF only, a limitation particu-
larly relevant to conditions where blood flow is diffusely
abnormal e.g. widespread CAD or microvascular coronary
dysfunction. Quantitative assessment of myocardial blood
flow (MBF) overcomes this limitation, indeed it has been
used to provide pathophysiological insight into conditions
where microvascular disease is manifest [3]. In addition,
quantitative measurement of MBF appears to allow more
accurate evaluation of ischaemic burden [4], is potentially
advantageous in patients with differing degrees of epicardial
stenoses and may also allow more precise characterization
of changes in MBF following therapeutic interventions.
Studies using positron emission tomography (PET) have
demonstrated the superiority of MBF quantification over
qualitative and semi-quantitative methods for identifica-
tion of CAD [5,6].
CMR MBF quantification has been validated in animal
models against microspheres and in healthy volunteers
and patients with CAD against PET, on per segment or
per sector levels [7-9]. More recently voxel-wise CMR as-
sessment of MBF has been validated against microspheres
in canines, although to date voxel-wise assessment has not
been validated in humans with CAD [10]. Voxel-wise as-
sessment potentially allows superior identification of the
extent of ischaemia and as such may be particularly helpful
in conditions where ischaemia is confined to limited re-
gions of myocardium e.g. the subendocardium, although at
the potential cost of reduced signal to noise. However, des-
pite quantitative perfusion CMR being applied increasingly
widely in the research setting, it has not yet become a clin-
ical tool. One of the main reasons for this is the consider-
able disparity that exists in quantification methodology.
The aim of this study was primarily to evaluate the ef-
fect that common methodological differences in CMR
MBF quantification have on voxel-wise measurement of
MBF in patients with CAD and in healthy volunteers.
Specifically we aimed to assess the impact of accounting
for the non-linear relationship between contrast agent
concentration and signal intensity, arterial input func-
tion (AIF) location and method of deconvolution. Inter-
observer variability was assessed in order to put the
magnitude of the effect of these methodological varia-
tions into context. Finally, CMR-derived MBF was com-
pared with MBF quantified using PET.Methods
Patients and study design
Patients with CAD with typical symptoms of angina and
with known significant stenoses (>75% luminal narrowing)
of one or more epicardial coronary arteries, as determined
angiographically (qualitative analysis), were prospectively
recruited. All patients awaiting elective percutaneous cor-
onary intervention (PCI) at a tertiary UK cardiac centre
(University Hospital of South Manchester NHS Trust)
over a 6-month period were screened for study eligibility.
Exclusion criteria included left main stem disease, severe
proximal 3-vessel disease, acute coronary syndrome within
6-weeks, estimated glomerular filtration rate of 35
mL/min/1.73 m2 or less and contraindications to CMR
or adenosine infusion.
In addition, healthy volunteers were recruited through
hospital and university advertisement. Volunteers were
completely asymptomatic with no known risk factors or
history of cardiac disease, normal physical examination
and normal ECG (i.e. they were not patients who had
been referred for CMR that was subsequently found to
be normal).
Patients underwent CMR and rubidium-82 (Rb-82)
PET, the order of which was determined randomly. No pa-
tient had an interim cardiovascular event or coronary re-
vascularization procedure. Healthy volunteers underwent
CMR only. An ethics committee of the UK National
Research Ethics Service approved the study (11/NW/
0045) and written informed consent was obtained from all
participants. The work was conducted according to the
Declaration of Helsinki.
Cardiovascular magnetic resonance image acquisition
Subjects were instructed to abstain from caffeine for a
minimum of 12 hours prior to CMR and PET imaging.
CMR was performed using a 1.5 T scanner (Avanto;
Siemens Healthcare, Germany) equipped with a 32-
element phased-array coil. Using a saturation recovery
gradient echo sequence, basal, mid and apical left ven-
tricular (LV) short-axis images were acquired every heart-
beat during pharmacological vasodilation (‘stress’) and at
rest. For stress imaging, intravenous adenosine (140 μg/
kg/min) was administered via a large peripheral vein for
3-minutes prior to, and during, data acquisition. A
0.05 mmol/kg bolus of gadolinium-based contrast agent
(gadopentetate dimeglumine; Gd-DTPA; Magnevist; Bayer
Healthcare, Germany) was administered intravenously at
5 mL/s followed by a 30 mL saline flush. Rest imaging was
performed 10 minutes after stress imaging with a further
0.05 mmol/kg of contrast agent. Typical image parameters
included: FOV 270 × 360 mm, matrix 120 × 160, slice
thickness 10 mm, acquired image resolution 2.5 × 2.5 × 10
mm, saturation recovery time 120 ms, echo time 1.07 ms,
repetition time 2.13 ms, flip angle 12°, parallel imaging
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image acquisition, a further 0.1 mmol/kg of contrast agent
was administered (‘top-up’) to bring the total dose to
0.2 mmol/kg.
In addition, steady-state free precession (SSFP) cine
images were acquired in standard long-axis views and in
a stack of short-axis slices covering the LV. Standard late
gadolinium enhancement (LGE) imaging was performed
at least 10 minutes following the contrast agent ‘top-up’
using spoiled gradient echo segmented inversion recov-
ery, and phase sensitive inversion recovery (PSIR) seg-
mented gradient echo, sequences.
Positron emission tomography image acquisition
Rb-82 was supplied from a CardioGen-82® strontium-
82/Rb-82 generator manufactured for Bracco (Bracco
Diagnostics Inc, USA). Imaging was performed using a
Siemens Biograph mCT scanner (Siemens Healthcare,
Germany) with Lutetium Oxyorthosilicate crystals and
extended axial FOV. Patients underwent serial rest then
stress imaging as per the routine clinical protocol at our in-
stitution. A computed tomography (CT) scout view over
the chest was performed for positioning followed by a low-
dose CT scan (120 kV, quality reference effective mAs = 11,
rotation 0.5 s, pitch 1.5, collimation 16.0 × 1.2 mm) to pro-
vide attenuation-correction of the rest emission data.
1110 MBq Rb-82 was infused intravenously at a flow rate
of 50 mL/min. List mode 3D data acquisition was started
with the tracer infusion and continued for 7 min. For stress
imaging, intravenous adenosine (140 μg/kg/min) was ad-
ministered via a large peripheral vein for 4.5 min. Intraven-
ous Rb-82 infusion and list mode acquisition began 3 min
after the start of the adenosine infusion following the same
protocol as rest imaging. Registration between PET and
CT images was checked for evidence of patient motion
and manual adjustments were made prior to reconstruc-
tion to correct for minor motion. In cases of significant pa-
tient motion between PET and CT, an additional low dose
CT was acquired at the end of the study. Both rest and
stress dynamic images used for MBF quantification were
reconstructed into 19 time frames (1 × 10 s, 10 × 5 s, 3 ×
20 s, 2 × 30 s, 3 × 60 s) on a 128×128 matrix using ordered
subset expectation maximization (OSEM) reconstruction
(2 iterations, 24 subsets) with 3mm Gaussian post-filter.
Data analysis
CMR myocardial blood flow quantification
Endocardial and epicardial contours were drawn on the
perfusion images using Osirix Imaging Software (Pixmeo;
Switzerland; v4.0). Additional regions of interest (ROI)
were drawn in the blood pool on the basal and mid-
ventricular images, avoiding papillary muscles and trabecu-
lae, for AIF determination. The anterior right ventricular
septal insertion point was marked. ROIs were manuallytranslated on each perfusion image of the same slice in
order to compensate for rigid-body translational motion.
Calculation of contrast agent concentration
Saturation of the signal occurs at high contrast agent con-
centrations due to the non-linear relationship between
contrast agent concentration and signal intensity. If not
accounted for this leads to an underestimate of the AIF
peak and a resulting overestimate of MBF. The method
described by Biglands et al. [11] was used to convert the
signal intensity in both the blood pool and myocardium to
contrast agent concentration in order to account for the
non-linearity and correct for signal saturation. An as-
sumed value for native blood T1 was used to calculate the
sequence calibration constant (dependent on receiver gain,
proton density and flip angle) from the pre-contrast signal
intensity in the blood pool of the stress image dataset and
to convert the stress signal AIF to contrast agent concen-
tration using a value for the relaxivity of gadopentetate
dimeglumine of 4.5 s-1mM-1 [12]. The calibration constant
was assumed constant across both myocardium and blood
and between the stress and rest image acquisitions in
order to convert the remaining signal curves to contrast
agent concentration.
Deconvolution methods
Model-independent analysis of dynamic contrast en-
hanced CMR data is based on the central volume
principle, which relates the amount of tracer in a tissue re-
gion over time to the arterial input of tracer to the region
[13]. For a single input system which is linear (i.e. the re-
sponse scales with the input) and stationary (i.e. the re-
sponse is independent of time of arrival), the tissue
contrast agent concentration curve, C(t) can be expressed
as the convolution of the arterial input function, AIF(t),
and the tissue impulse response function. The initial value
of the tissue impulse response function is equal to the
blood flow into the region, MBF such that
C tð Þ ¼ MBF AIF tð Þ ⊗ R tð Þð Þ ð1Þ
where R(t) is the normalized impulse response function.
R(t) represents the probability that a tracer molecule
that entered the tissue region at t = 0 is still present in
the tissue at time t and is also known as the tissue resi-
due function. MBF can therefore be determined by a dir-
ect deconvolution of the measured contrast agent
concentration in the LV cavity, i.e. the AIF(t), from the
measured myocardial tissue contrast agent concentra-
tion, C(t). Deconvolution is, however, numerically un-
stable and requires some form of regularization. In this
study three commonly used approaches were applied
and compared.
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This approach assumes a parametric form for the im-
pulse response function and is based on the observation
by Axel [14] that the shape of the expected tissue im-
pulse response resembles a function from quantum me-
chanics known as a Fermi function
R tð Þ ¼ 1
e t−t0ð Þ=τ þ 1 ð2Þ
where t0 and τ determine the shape of R(t) but have no
direct physiological relevance. MBF may then be deter-
mined by a non-linear least squares fit to the myocardial
tissue concentration curve where the fitting function is
formed using Eq. (1) with R(t) given by Eq. (2).
Truncated singular valued decomposition
Direct deconvolution of the AIF(t) from the tissue concen-
tration curve is achieved using a singular valued decom-
position (SVD) to solve the least squares minimization
problem
minX∥AX ‐ B∥ ð3Þ
where the matrix A is the convolution matrix formed
from the AIF, the vector B is given by C(t) and the vec-
tor X is the impulse response function. The simplest
method of regularization is the truncated singular valued
decomposition (TSVD), most commonly applied in
quantification of cerebral blood flow in which all the sin-
gular values below a particular threshold are set to zero
(truncated) [15,16]. The threshold value is usually set to
be a fraction of the largest singular value [15,17].
Tikhonov regularization with b-splines
Tikhonov regularization is an alternative to TSVD in
which a quadratic constraint is added to Eq. (3)
minX ∥AX ‐ B∥2 − λ2∥LX∥2
  ð4Þ
resulting in a smooth truncation of the singular values with
a regularization parameter, λ. In zeroth-order Tikhonov
regularization L is the identity matrix and in first order
Tikhonov regularization L is the finite difference operator.
The inclusion of the finite difference operator, which is
an approximation to a first derivative, favours solutions
that are relatively flat. One advantage of Tikhonov
regularization is the fact that, unlike TSVD, the solution
depends on the choice of the regularization parameter in
a continuous manner, facilitating a selection of an
optimum value for the regularization parameter using L-
curve analysis [18]. As a further constraint, the impulse
response function was parameterized as a sum of 15 b-
splines. This approach, introduced by Jerosch-Herold
et al. [19], imposes smoothness and continuity on theimpulse response function and has been applied in a
number of quantitative CMR perfusion studies [20].
Each of the three deconvolution approaches (Fermi func-
tion fitting, TSVD and first-order Tikhonov regularization
with b-splines) was applied on a voxel-wise basis within
the myocardial ROIs on each slice to generate maps of
MBF. Data was restricted to the first pass of the contrast
agent through the heart, which was automatically detected
using the AIF from the LV blood pool. All analysis was car-
ried out using algorithms written in-house using Matlab
(The Mathworks; USA; v2009A). Tikhonov regularization
utilized Matlab routines from the “Regularization Tools” li-
brary by Hansen [21].
MBF maps were segmented according to the American
Heart Association/American College of Cardiology 16-
segment model and median voxel MBF in each segment
was recorded. Comparison was made between segmental
MBF calculated using: 1. contrast agent concentration
curves versus signal intensity curves; 2. mid-ventricular
versus basal-ventricular AIF extraction; 3. each deconvolu-
tion method. Except for when the effect of saturation cor-
rection and AIF location respectively were specifically
being assessed, saturation correction and basal slice AIF
extraction were used throughout.
PET myocardial blood flow quantification
MBF quantification was performed using a commercially
available software package (Syngo MBF, Siemens Health-
care, Germany), which has been validated using N-13 am-
monia PET and shown to have high observer repeatability
[22,23]. The software describes the pharmacokinetic be-
haviour of Rb-82 using a single compartment model
CT tð Þ ¼ Ca tð Þ ⊗ K1e−kt ð5Þ
where CT(t) is the myocardial activity concentration and
Ca(t) is the arterial blood concentration. The response
function of the myocardium is modelled by an exponen-
tial and K1 is the uptake ratio from blood into the tissue
[22]. Processing was highly automated although operator
intervention was possible to confirm or modify the auto-
matic re-orientation of the LV and to apply motion
correction if needed. The myocardium was defined auto-
matically and sampled into 505 segments according to a
cylindrical-spherical model. Myocardial tissue time-
activity curves were obtained at each time frame. The
arterial input function was obtained from the dynamic
sequence by averaging the activity in a 1 × 3 cm cylin-
drical region-of-interest placed automatically in the basal
LV cavity. Kinetic model fitting using non-linear regres-
sion was performed on each of the 505 polar-map
sectors to compute MBF values for each voxel, which
were then averaged to calculate segmental values. The






n = 9 n = 9
Male 8 (89%) 7 (78%) 0.527
Age 68 ± 5 48 ± 9 <0.001
BMI (kg/m2) 26.6 ± 2.7 27.0 ± 3.4 0.783
eGFR (mL/min/m2) 78 ± 22 86 ± 13 0.375
Hypertension 5 (56%) 0
Diabetes 2 (22%) 0
Current/previous smoker 1 (11%) / 4 (44%) 0
Previous MI 4 (44%) 0
Previous PCI 4 (44%) 0
Previous CABG 1 (11%) 0
Coronary disease
Left anterior descending 4 (44%) -
Circumflex 2 (22%) -
Right 6 (67%) -
Angina (CCS)
Class 1 1 (11%) -
Class 2 4 (44%) -
Class 3 4 (44%) -
LVEDVI (mL/m2) 87 ± 19 86 ± 8 0.871
LVESVI (mL/m2) 36 ± 19 28 ± 4 0.223
LVEF (%) 61 ± 11 68 ± 4 0.086
LV Mass I (g/m2) 46 ± 9 48 ± 8 0.694
BMI indicates body mass index; eGFR estimated glomerular filtration rate; MI
myocardial infarction; PCI percutaneous coronary intervention; CABG coronary
artery bypass graft; CCS Canadian Cardiovascular Society; EDV end diastolic
volume; ESV end-systolic volume. The suffix I indicates indexed to body
surface area.
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rection [23].
Segmental MBF and myocardial perfusion reserve
(MPR, calculated by dividing stress MBF by rest MBF)
measured using CMR and PET were compared.
LV volumetric analysis
LV mass, end-diastolic volume (EDV), end-systolic volume
(ESV) and ejection fraction (EF) were quantified from CMR
SSFP images using CMRtools (Cardiovascular Imaging
Solutions, UK).
Interobserver variability
All CMR studies were independently analysed by a second
observer in order to assess Interobserver repeatability.
Statistical analysis
All data was analysed in a blinded fashion, with independ-
ent analysis of CMR and PET data. Statistical analysis was
performed using SPSS (IBM, USA; v19). Continuous vari-
ables are expressed as mean ± SD unless stated. An
independent-samples t test (or Mann–Whitney U test
where appropriate) was used to compare patient and vol-
unteer demographic data. Agreement was evaluated using
Bland-Altman analysis by calculating mean difference
(bias) and 95% limits of agreement (i.e. mean difference ±
2 SD). The significance of the differences was assessed
using generalized estimating equations (GEE) in order to
adjust for the repeated measurements within each subject.
For the same reason, regression analysis using GEE was
used to assess the relationship between CMR-derived
MBF and PET-derived MBF. Within-subject and between-
subject correlations were calculated using the methods de-
scribed by Bland et al. [24,25].
Results
Study population
Eighteen subjects were recruited, comprising 9 patients
with CAD and 9 healthy volunteers. Participant charac-
teristics are displayed in Table 1.
Contrast agent concentration versus signal intensity
Mean MBF calculated using contrast agent concentra-
tion curves was significantly higher than when signal in-
tensity curves were used (Table 2). The degree of
overestimation increased as MBF increased (Figure 1A).
AIF location
Mean MBF was significantly higher when the AIF was ex-
tracted from the blood pool in the mid-ventricular short-
axis images compared to when it was extracted from the
blood pool in the basal-ventricular images (Table 2). The
magnitude of the difference increased as MBF increased, in-
deed at rest there was no significant difference (Figure 1B).Method of deconvolution
Overall mean MBF did not differ significantly between
Fermi and Tikhonov methods and between Fermi and
TSVD methods (Table 3). Overall mean MBF calculated
using TSVD was significantly lower than MBF calculated
using Tikhonov regularization, although the absolute differ-
ence was small (0.06 mL/min/g). Limits of agreement be-
tween all deconvolution methods were narrow (Figure 2).
Mean MBF during stress did not differ significantly be-
tween deconvolution methods but at rest MBF calcu-
lated using the Fermi technique was significantly higher
than with the other methods, although the absolute dif-
ferences were again small. Limits of agreement between
all methods were narrow for both stress and rest MBF
values.
Interobserver repeatability
Observer agreement for measurement of MBF was
moderate, with 95% limits of agreement (± 2 standard
Table 2 Effect of saturation correction and arterial input











1.10 ± 0.64 1.55 ± 0.63 0.66 ± 0.20
Signal intensity 1.80 ± 1.03 2.51 ± 1.00 1.09 ± 0.33
p value <0.001 <0.001 <0.001
95% limits of
agreement
−0.20 to 1.60 0.01 to 1.92 0.02 to 0.85
B. AIF location
Basal ventricular 1.10 ± 0.64 1.55 ± 0.63 0.66 ± 0.20
Mid ventricular 1.22 ± 0.80 1.79 ± 0.75 0.64 ± 0.23
p value 0.002 <0.001 0.392
95% limits of
agreement
−0.40 to 0.64 −0.36 to 0.85 −0.23 to 0.21
95% limits of agreement represent mean difference ± 2 standard deviations.
For part A, the limits of agreement refer to MBF measured using raw signal
intensity curves minus MBF measured using calculated contrast agent
concentration curves (to correct for signal saturation); and for part B, MBF
measured using a mid-ventricular-positioned AIF minus MBF measured using a
basal-ventricular-positioned AIF.
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lows: Fermi: -0.62 to 0.54 mL/min/g; Tikhonov: -0.83 to
0.63 mL/min/g; TSVD: -0.64 to 0.57 mL/min/g.
Comparison with PET
Median interval between CMR and PET was 7 days
(interquartile range 4–25). Resting heart rate (54 ± 6 v
55 ± 6 bpm; p = 0.71), systolic blood pressure (118 ± 14 v
125 ± 18 mmHg; p = 0.14) and rate pressure product
(6493 ± 870 v 7108 ± 1258 mmHg.bpm; p = 0.18), as well
as stress heart rate (75 ± 9 v 73 ± 13 bpm; p = 0.46), sys-
tolic blood pressure (110 ± 13 v 109 ± 13 mmHg; p =
0.66) and rate pressure product (8230 v 7947 mmHg.
bpm; p = 0.46) did not differ significantly between CMR
and PET scans. Quantitative PET analysis was not pos-
sible in one patient due to substantial movement
artefact.
There was a significant linear relationship between
CMR-derived MBF and PET-derived MBF using each
CMR deconvolution method (p < 0.001 for each using
GEE; Figure 3). For each method of deconvolution, the
within-subject and between-subject correlations between
CMR-derived MBF and PET-derived MBF were signifi-
cant (Fermi-CMR v PET: within-subject r = 0.63, p <
0.001; between-subject r = 0.91, p < 0.01; Tikhonov-CMR
v PET: within-subject r = 0.47, p < 0.001; between-subject
r = 0.81, p < 0.02; TSVD-CMR v PET: within-subject
r = 0.53, p < 0.001; between-subject r = 0.82, p < 0.02).
Nevertheless, as is evident from Table 4 and the Bland-
Altman plots in Figure 3, mean CMR-derived MBF,using each of the deconvolution methods, was significantly
lower than mean PET-derived MBF. The magnitude of the
difference increased as blood flow increased, although
there was greater heterogeneity at higher blood flow
values. In spite of this however, mean CMR-derived MPR
measured using Fermi and TSVD deconvolution methods
was not significantly different from PET-derived MPR
(Table 4, Figure 4). Whilst mean Tikhonov-CMR-derived
MPR was significantly lower than PET-derived MPR, the
absolute difference was small and the bias was consistent
across the entire range of MPR values. Agreement be-
tween PET-derived MPR and MPR measured using each
of the CMR deconvolution methods was moderate.
Significantly lower mean stress MBF and MPR values
were seen in stenotic coronary territories compared to
remote territories with PET and with each of the CMR
deconvolution methods (Table 5, Figure 5). No differ-
ence was seen in mean resting MBF between stenotic
and remote territories using CMR, although a small dif-
ference was seen with PET.
Discussion
This paper demonstrates the differences in CMR-derived
measurement of MBF that result from common variations
in quantification methodology. Although we have used
voxel-wise analysis, the methodological steps assessed are
generic and would be expected to impact on segmental/
sector-wise analysis similarly. In addition, this study repre-
sents the first validation of voxel-wise CMR MBF quantifi-
cation against PET in patients with CAD.
CMR is an attractive alternative to PET for measure-
ment of MBF. Advantages of CMR include higher spatial
and temporal resolution, more accurate endocardial
border definition hence less potential for blood pool spill-
over, wider availability, absence of ionizing radiation and
its multiparametric nature which allows blood flow to be
interpreted in the context of accurate functional and via-
bility data obtained during the same scan [26]. Disadvan-
tages include vulnerability to arrhythmias, contrast agents
that are potentially toxic in severe renal impairment and
that have both intra- and extravascular components, sus-
ceptibility artefact and the need for prolonged respiratory
suspension. Nevertheless, CMR MBF quantification has
been increasingly applied in the research setting.
The study cohort was chosen in order to ensure sub-
stantial regional variation in MBF, thus allowing evalu-
ation of methodological differences in CMR MBF
quantification over a wide range of MBF values and
meaningful segmental comparison between CMR and
PET. Reflecting the extent of CAD (59 of 144 segments
(41%) had visually apparent perfusion defects on qualita-
tive CMR analysis), mean stress MBF and MPR mea-
sured with both CMR and PET in patients with CAD
were relatively low.
Figure 1 Saturation effects and AIF location. Bland-Altman plots displaying the agreement between MBF quantified using raw signal intensity
curves versus calculated contrast agent concentration curves (to correct for signal saturation) (A), and using AIF extracted from mid-ventricular
short-axis images compared to basal-ventricular images (B). Solid line represents mean difference; dashed lines represent ± 2 standard deviations.
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Despite using a contrast agent dose that is half of that
most commonly used clinically, Figure 1A demonstrates
that considerable saturation effects remained and high-
lights the importance of accounting for the non-linear
relationship between contrast agent concentration and
signal intensity and correcting for signal saturation.
Higher MBF values were also observed when AIF(t) was
extracted from the blood pool in the mid- compared to
the basal-ventricular short-axis LV slice (Figure 1B). It is
likely that inadvertent inclusion of trabeculae within the
mid-ventricular AIF ROI, which were more difficult to
avoid in the smaller mid-ventricular cavity, had a similar
truncating effect, hence the use of basal images for AIF
extraction throughout the remainder of the current
study. Potential differences in contrast-blood mixingbetween ventricular levels may also have contributed to
the observed difference in estimated MBF.
Deconvolution methods
Many deconvolution algorithms have been described,
which can broadly be classified into parametric and non-
parametric techniques. Parametric deconvolution as-
sumes a shape for the tissue impulse response function.
Fermi function parameterization, the most widely ap-
plied parametric deconvolution method for MBF quanti-
fication, is relatively straightforward to apply and MBF
measurements using this method have been validated
against microspheres [7,27]. The main disadvantage of
Fermi parameterization is that the assumed form of the
impulse response function may not be appropriate, po-
tentially leading to systematic errors in MBF estimation.
Table 3 Effect of method of deconvolution on myocardial blood flow quantification
A. Mean values
Fermi Tikhonov TSVD p value
Overall MBF (mL/min/g) 1.10 ± 0.64 1.15 ± 0.57 1.09 ± 0.56 0.023
Stress MBF (mL/min/g) 1.55 ± 0.63 1.55 ± 0.53 1.48 ± 0.54 0.105
Rest MBF (mL/min/g) 0.66 ± 0.20 0.76 ± 0.24 0.70 ± 0.20 <0.001
B. Mean differences and limits of agreement
Mean difference p-value 95% limits of agreement
Overall MBF (mL/min/g)
Fermi – Tikhonov −0.05 0.160 −0.58 to 0.48
Fermi – TSVD 0.01 1.000 −0.41 to 0.44
Tikhonov – TSVD 0.06 0.025 −0.37 to 0.51
Stress MBF (mL/min/g)
Fermi – Tikhonov 0.00 1.00 −0.62 to 0.61
Fermi – TSVD 0.07 0.345 −0.44 to 0.59
Tikhonov – TSVD 0.08 0.148 −0.42 to 0.57
Rest MBF (mL/min/g)
Fermi – Tikhonov −0.10 <0.001 −0.52 to 0.32
Fermi – TSVD −0.04 0.021 −0.32 to 0.24
Tikhonov – TSVD 0.06 0.119 −0.32 to 0.45
95% limits of agreement represent mean difference ± 2 standard deviations. Other abbreviations as per Tables 1 and 2. p values in Part A refer to the significance
of the mean difference between the three deconvolution methods; p values in part B are those obtained on post hoc analysis.
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http://jcmr-online.com/content/16/1/11Non-parametric approaches do not assume a functional
form for the tissue impulse response function, however
due to the numerically unstable nature of the deconvolu-
tion process, constraints in the form of regularization are
still required. The solution obtained depends on the choice
of regularization parameter. Tikhonov regularization,
which results in a smooth truncation of the singular
values, allows the use of methods such as L-curve analysis
or generalized cross-validation to find the optimum
regularization parameter directly from the data. This offers
potential advantages over TSVD in which an arbitrary
threshold (commonly set at 20% of the maximum singular
value) is used. Tikhonov regularization, combined with an
additional constraint of a b-spline representation of the
impulse response function, is the most commonly applied
non-parametric technique for estimating MBF and has
been validated with microspheres [19,20]. However the
implementation is considerably more involved than that of
either Fermi parameterization or TSVD.
In this study, the difference in estimated MBF between
deconvolution techniques was minimal. Indeed, the 95%
limits of agreement for measurement of MBF between
deconvolution techniques were similar (or smaller) in
magnitude to the limits of agreement between AIF ex-
traction locations (i.e. basal versus mid-ventricular slice)
and to the limits of agreement between observers. In
keeping with these findings Pack et al. [28], who com-
pared four quantitative analysis techniques in healthyvolunteers (although with non-identical doses of con-
trast agent and without external validation), found no
difference in MBF measurements between a model-free
deconvolution technique, a two-compartment model
and Patlak plot analysis, although stress MBF was higher
with Fermi function parameterization. In the current
study, MBF measured using each deconvolution tech-
nique showed a significant correlation with PET-derived
MBF, with correlation coefficients that are in keeping
with previous studies comparing sector-wise CMR MBF
measurements with PET [8,9]. Perhaps most import-
antly, there was a very clear demarcation in mean stress
MBF and MPR between stenotic and remote coronary
territories using each quantification method.
Comparison with PET
MBF measured using Fermi parameterization showed
the closest correlation with PET-derived MBF, whereas
the non-parametric techniques, particular Tikhonov
regularization, displayed greater heterogeneity. As a pos-
sible explanation for these findings, Zarinabad et al. [29]
demonstrated voxel-wise MBF quantification with Fermi
analysis to be most robust to noise in a physiologically
realistic two-compartment myocardial perfusion phan-
tom, whereas Tikhonov regularization was the least ro-
bust. Nevertheless, each of the CMR quantification
techniques in the current study underestimated MBF
compared to PET, the degree of which became more
Figure 2 Comparison of deconvolution methods. Bland-Altman plots displaying the agreement between MBF measured using Fermi function
(Fermi), Tikhonov regularization (Tikhonov) and TSVD methods of deconvolution. Solid line represents mean difference; dashed lines represent ± 2
standard deviations.
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http://jcmr-online.com/content/16/1/11apparent as MBF increased. Whilst the dose of contrast
agent and method of accounting for saturation used here
are well described [11], that this effect was seen with alldeconvolution methods could suggest an inaccuracy in the
saturation correction algorithm. However Hsu et al. [10],
who evaluated voxel-wise CMR MBF quantification
Figure 3 Comparison of CMR and PET-derived MBF. CMR-derived MBF measured using Fermi function parameterization (Fermi, A), Tikhonov
regularization (Tikhonov, C) and TSVD (E) deconvolution methods plotted against PET-derived MBF, with corresponding Bland-Altman plots
(B, D, F respectively).
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http://jcmr-online.com/content/16/1/11against microspheres in a canine model with a dual-bolus
technique, also found CMR (parametric deconvolution
analysis) to underestimate MBF, the magnitude of whichincreased as MBF increased. The authors demonstrated
that the underestimation was not due to an issue intrinsic
to voxel-level quantification, with the same degree of
Table 4 Comparison of CMR and PET-derived myocardial blood flow and myocardial reserve index
A. Mean values
PET Fermi Tikhonov TSVD
Overall MBF (mL/min/g) 1.23 ± 0.72 0.90 ± 0.44 1.05 ± 0.51 0.94 ± 0.47
Stress MBF (mL/min/g) 1.62 ± 0.81 1.16 ± 0.47 1.29 ± 0.51 1.21 ± 0.50
Rest MBF (mL/min/g) 0.84 ± 0.27 0.64 ± 0.20 0.80 ± 0.35 0.67 ± 0.17
MPR 1.97 ± 0.87 1.97 ± 1.13 1.73 ± 0.73 1.87 ± 0.79
B. Mean differences and limits of agreement
Mean difference p-value 95% limits of agreement
Overall MBF (mL/min/g)
PET – Fermi 0.35 <0.001 −0.56 to 1.26
PET – Tikhonov 0.19 0.014 −0.90 to 1.29
PET – TSVD 0.30 <0.001 −0.73 to 1.32
Stress MBF (mL/min/g)
PET – Fermi 0.48 <0.001 −0.65 to 1.61
PET – Tikhonov 0.34 0.004 −0.95 to 1.63
PET – TSVD 0.43 0.001 −0.89 to 1.75
Rest MBF (mL/min/g)
PET – Fermi 0.22 <0.001 −0.28 to 0.72
PET – Tikhonov 0.05 0.531 −0.72 to 0.82
PET – TSVD 0.17 <0.001 −0.32 to 0.66
MPR
PET – Fermi 0.02 0.869 −1.41 to 1.38
PET – Tikhonov 0.25 0.028 −0.99 to 1.50
PET – TSVD 0.14 0.200 −1.06 to 1.34
95% limits of agreement represent mean difference ± 2 standard deviations. Other abbreviations as per previous Tables.
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et al. [8] and Fritz-Hansen et al. [30], who compared
sector-wise CMR-derived MBF against O-15 and N-13
PET respectively in healthy volunteers, also found CMR to
underestimate MBF compared to PET, again with greater
underestimation at higher MBF values. In contrast Morton
et al. [9], who compared sector-wise CMR MBF (dual-bolus
technique, Fermi analysis) with N-15 PET in patients with
CAD, found mean MBF to be higher with CMR than with
PET although the significance of the difference was not
stated. Nevertheless as is evident from their presented
Bland-Altman plots, while CMR overestimated MBF at low
MBF values, CMR underestimated MBF at higher MBF
values. The reasons for these consistent differences between
CMR and PET are not clear, but may relate to differences
in quantification methodology between modalities.
In the current study, the underestimation of both rest
and stress MBF was largely cancelled out by calculation of
MPR, which was not significantly different from PET
using Fermi and TSVD methods although a small under-
estimation was seen with Tikhonov regularization, findings
which are consistent with the other discussed studies
[8,9,30].Precision
Interobserver repeatability for MBF quantification with
CMR has not been widely reported. 95% limits of agree-
ment were used to assess interobserver repeatability here
in order to allow comparison with variability due to the
investigated methodological differences, but they have not
previously been reported. Morton et al. [9], using Fermi
function parameterization in patients with CAD, reported
interobserver coefficients of variation of 16% and 18%
respectively for stress and rest MBF using sector-wise
(coronary territory) analysis with automated myocardial
border detection. The slightly higher coefficients of vari-
ation in the current study (stress MBF 24%, rest 26% for
Fermi function) are likely to reflect the segmental-wise
(rather than per coronary territory) comparison between
observers and the manual method of defining the myocar-
dial borders (as well as the AIF ROI and right ventricular
septal insertion point), both of which would inherently be
associated with greater variability.
Limitations
The number of patients with CAD included was small and
reflects the reticence of such patients to undergo two
Figure 4 Comparison of CMR and PET-derived MPR. Bland-Altman plots displaying the agreement between CMR MPR measured using Fermi
function (Fermi), Tikhonov regularization (Tikhonov) and TSVD deconvolution methods and MPR measured using PET.
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http://jcmr-online.com/content/16/1/11additional investigations prior to PCI. Nevertheless, overall
sample size was comparable to other methodological stud-
ies of this type and with appropriate statistical adjustment,
segmental analysis allowed for meaningful investigation.
The methodological steps evaluated are not exhaustive,
but do represent some of the major variations in MBF
quantification.The selection of patients with CAD required >75%
coronary luminal stenosis as determined visually. The
limitations of visual assessment of angiography are well
recognized however the purpose of recruiting such pa-
tients was simply to ensure substantial regional variation
in MBF, which was achieved. (We did not aim to assess
diagnostic performance). In any case, in all patients the
Table 5 CMR and PET-derived myocardial blood flow and








PET 1.20 ± 0.66 1.89 ± 0.78 <0.001
Fermi 0.81 ± 0.29 1.36 ± 0.47 <0.001
Tikhonov 0.99 ± 0.36 1.47 ± 0.55 <0.001
TSVD 0.90 ± 0.33 1.38 ± 0.54 <0.001
Rest MBF (mL/min/g)
PET 0.80 ± 0.26 0.86 ± 0.28 0.034
Fermi 0.62 ± 0.18 0.62 ± 0.17 0.917
Tikhonov 0.79 ± 0.46 0.79 ± 0.24 0.926
TSVD 0.66 ± 0.20 0.68 ± 0.17 0.618
MPR
PET 1.53 ± 0.68 2.25 ± 0.88 <0.001
Fermi 1.35 ± 0.47 2.40 ± 1.31 <0.001
Tikhonov 1.35 ± 0.47 1.95 ± 0.79 0.004
TSVD 1.41 ± 0.49 2.10 ± 0.86 <0.001
Figure 5 Example voxel-wise MBF maps. CMR MBF maps quantified using
C and F, mid-ventricular D and G, apical-ventricular E and H), Tikhonov regula
PET polar plots in a patient with a significant stenosis of the right coronary art
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http://jcmr-online.com/content/16/1/11degree of coronary disease was felt sufficient to warrant
PCI clinically.
It is recognized that Rb-82 PET is not an ideal gold
standard, with myocardial extraction of Rb-82 known to
become non-linear as flow increases. Correction algo-
rithms, which have generally been developed in small
numbers of healthy volunteers only, are therefore re-
quired for MBF estimation and inevitably lead to inac-
curacies [22]. Nevertheless Rb-82 PET has been well
validated and does provide an external validation of the
CMR-derived MBF measurements and as discussed, our
findings are in keeping with most previous comparisons
of sector-wise CMR MBF quantification with N-13 and
O-15 PET [22,31].Conclusions
This paper demonstrates the feasibility of voxel-wise
CMR quantification of MBF in patients with CAD and
healthy volunteers and shows the effect that differences
in quantification methodology have on MBF measure-
ments. The magnitude of the difference in estimated
MBF between deconvolution methods is no greater than
differences due to simple methodological factors suchFermi function parameterization (stress C-E, rest F-H; basal-ventricular
rization (I-N) and TSVD (O-T), with corresponding stress (A) and rest (B)
ery.
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http://jcmr-online.com/content/16/1/11as short-axis slice used for AIF extraction, or indeed dif-
ferences between observers. Standardization of the
quantification process will aid comparison between
studies and may help CMR MBF quantification enter
clinical use.
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